Delcath Systems (DCTH) EPS (Diluted) Growth (1y) (2012 - 2026)
Delcath Systems (DCTH) EPS (Diluted) Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | -47.60% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 44.49% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 18.72% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 15.24% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | -25.88% |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 44.97% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 15.81% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 71.72% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 13.96% |
| 10 | Delcath Systems | 602.63 Mn | 506.70 Mn | 26.15 Mn | 0.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.17% |
| Mar 31, 2026 | -213.69% |
| Dec 31, 2025 | 60.15% |
| Sep 30, 2025 | -64.04% |
| Jun 30, 2025 | 113.83% |
| Mar 31, 2025 | 106.06% |
| Dec 31, 2024 | 83.38% |
| Sep 30, 2024 | 101.23% |
| Jun 30, 2024 | 32.85% |
| Mar 31, 2024 | 43.96% |
| Dec 31, 2023 | 24.23% |
| Sep 30, 2023 | -424.95% |
| Jun 30, 2023 | 40.46% |
| Mar 31, 2023 | 25.43% |
| Dec 31, 2022 | -33.20% |
| Sep 30, 2022 | 9.93% |
| Jun 30, 2022 | -9.69% |
| Mar 31, 2022 | 8.39% |
| Dec 31, 2021 | 70.51% |
| Sep 30, 2021 | 16.52% |